Loading...

Spotlight on Health - NAPSTV - Reolysin

1,397 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Feb 23, 2009

A CLINICAL TRIAL IS INVESTIGATING TREATMENTS USING A VERSION OF THE VIRUS,
CALLED REOLYSIN. DOCTOR KARL METTINGER, CHIEF MEDICAL OFFICER AT ONCOLYTICS, EXPLAINS: THERE IS A UNIQUE OPPORTUNITY HERE TO USE A NATURALLY OCCURRING VIRUS GIVEN THIS WAY, THAT IS SHOT INTO THE BODY, AND REACH THE DIFFERENT TARGETS IN METASTATIC CANCER PATIENTS WHERE THE VIRUS GETS SELECTIVELY TAKEN UP, REPLICATING AND BUILDING UP THE SMALL FACTORIES, WHICH THEN CONTINUE TO REPLICATE AND KILL CANCER.

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...